Sangamo Therapeutics Insider Trades

SGMO

Track insider trading activity from Sangamo Therapeutics executives and directors. See which insiders are buying and selling SGMO stock.

Trades Last 12 Months

SGMO Price

All Insider Trades for Sangamo Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Willoughby Scott B. Svp, CHIEF LEGAL Officer, SECY
Holding Value $47.3k 647,370 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$686 4,036 shares
$0.17
$0.07
Macrae Sandy President, CEO AND DIRECTOR
Holding Value $139k 1,895,043 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.14k 12,613 shares
$0.17
$0.07
Davis Gregory D Head Of Research & Technology
Holding Value $8.31k 113,654 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$277 1,630 shares
$0.17
$0.07
Jain Nikunj Principal Accounting Officer
Holding Value $17.2k 235,292 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$326 1,919 shares
$0.17
$0.07
Dubois Stringfellow Nathalie Svp-chief DEVELOPMENT OFFICER
Holding Value $24k 328,733 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$686 4,036 shares
$0.17
$0.07
Duraibabu Prathyusha PRINCIPAL FINANCIAL OFFICER
Holding Value $48.2k 660,042 shares
Last Trade
Jan 22, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.7k 36,676 shares
$0.40
$0.07
Dubois Stringfellow Nathalie Svp-chief DEVELOPMENT OFFICER
Holding Value $56k 766,089 shares
Last Trade
Aug 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.06k 1,792 shares
$0.59
$0.07
Parker H Stewart Director
Holding Value $8.23k 112,600 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Carey Robert Director
Holding Value $7.28k 99,600 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Markels John Director
Holding Value $7.05k 96,384 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Smith Karen L. Director
Holding Value $7.46k 102,100 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Horn Margaret A Director
Holding Value $6.04k 82,650 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Meyers James R Director
Holding Value $7.28k 99,600 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Beers Courtney Director
Holding Value $6.04k 82,650 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Holding Value $7.28k 99,600 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Pooler Amy Vp, HEAD OF RESEARCH
Holding Value $14.2k 193,923 shares
Last Trade
Aug 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$424 493 shares
$0.86
$0.07
Fontenot Jason D. Svp, Chief Scientific Officer
Holding Value $9.96k 136,270 shares
Last Trade
Nov 25, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$391 1,030 shares
$0.38
$0.07
Mcclung David Mark Evp, Chief Operating Officer
Holding Value $15.5k 212,471 shares
Last Trade
Nov 25, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$732 1,925 shares
$0.38
$0.07
Biogen Inc. 10% owner
Holding Value $1.29M 17,652,466 shares
Last Trade
Sep 26, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.06M 6,000,000 shares
$0.68
$0.07
Ramelmeier Rolf Andrew Evp, Technical Operations
Holding Value $12.5k 171,467 shares
Last Trade
May 25, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.33k 1,750 shares
$1.33
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up